Authors:
REDMOND DE
MAREK KL
NAFTOLIN F
LERANTH C
ROBBINS RJ
BUNNEY BS
ELSWORTH JD
VOLLMER T
HOFFER PB
ROTH RH
MAKUCH R
CHEN YT
SPENCER DD
Citation: De. Redmond et al., OUTCOME OF FETAL MESENCEPHALIC GRAFTS PLACED INTO THE STRIATUM OF 15 PATIENTS WITH PARKINSONISM - SITE OF PLACEMENT AND EXTENDED FUNCTIONAL-EFFECTS, Experimental neurology, 153(2), 1998, pp. 373-373
Citation: Aa. Grace et al., DOPAMINE-CELL DEPOLARIZATION BLOCK AS A MODEL FOR THE THERAPEUTIC ACTIONS OF ANTIPSYCHOTIC-DRUGS, Trends in neurosciences, 20(1), 1997, pp. 31-37
Citation: Ss. Shim et al., EFFECTS OF LESIONS IN THE MEDIAL PREFRONTAL CORTEX ON THE ACTIVITY OFMIDBRAIN DOPAMINE NEURONS, Neuropsychopharmacology, 15(5), 1996, pp. 437-441
Authors:
GOLDSTEIN LE
RASMUSSON AM
BUNNEY BS
ROTH RH
Citation: Le. Goldstein et al., ROLE OF THE AMYGDALA IN THE COORDINATION OF BEHAVIORAL, NEUROENDOCRINE, AND PREFRONTAL CORTICAL MONOAMINE RESPONSES TO PSYCHOLOGICAL STRESSIN THE RAT, The Journal of neuroscience, 16(15), 1996, pp. 4787-4798
Authors:
SKLAIRTAVRON L
SHI WX
LANE SB
HARRIS HW
BUNNEY BS
NESTLER EJ
Citation: L. Sklairtavron et al., CHRONIC MORPHINE INDUCES VISIBLE CHANGES IN THE MORPHOLOGY OF MESOLIMBIC DOPAMINE NEURONS, Proceedings of the National Academy of Sciences of the United Statesof America, 93(20), 1996, pp. 11202-11207
Citation: Wx. Shi et al., RITANSERIN, A 5-HT2A 2C ANTAGONIST, REVERSES DIRECT DOPAMINE AGONIST-INDUCED INHIBITION OF MIDBRAIN DOPAMINE NEURONS/, The Journal of pharmacology and experimental therapeutics, 274(2), 1995, pp. 735-740
Authors:
PRICE LH
SPENCER DD
MAREK KL
ROBBINS RJ
LERANTH C
FARHI A
NAFTOLIN F
ROTH RH
BUNNEY BS
HOFFER PB
MAKUCH R
REDMOND DE
Citation: Lh. Price et al., PSYCHIATRIC STATUS AFTER HUMAN FETAL MESENCEPHALIC TISSUE-TRANSPLANTATION IN PARKINSONS-DISEASE, Biological psychiatry, 38(8), 1995, pp. 498-505
Authors:
SASS KJ
BUCHANAN CP
WESTERVELD M
MAREK KL
FARHI A
ROBBINS RJ
NAFTOLIN F
VOLLMER TL
LERANTH C
ROTH RH
PRICE LH
BUNNEY BS
ELSWORTH JD
HOFFER B
REDMOND DE
SPENCER DD
Citation: Kj. Sass et al., GENERAL COGNITIVE-ABILITY FOLLOWING UNILATERAL AND BILATERAL FETAL VENTRAL MESENCEPHALIC TISSUE-TRANSPLANTATION FOR TREATMENT OF PARKINSONS-DISEASE, Archives of neurology, 52(7), 1995, pp. 680-686
Authors:
YOUNGREN KD
MOGHADDAM B
BUNNEY BS
ROTH RH
Citation: Kd. Youngren et al., PREFERENTIAL ACTIVATION OF DOPAMINE OVERFLOW IN PREFRONTAL CORTEX PRODUCED BY CHRONIC CLOZAPINE TREATMENT, Neuroscience letters, 165(1-2), 1994, pp. 41-44
Authors:
GOLDSTEIN LE
RASMUSSON AM
BUNNEY BS
ROTH RH
Citation: Le. Goldstein et al., THE NMDA GLYCINE SITE ANTAGONIST (-HA-966 SELECTIVELY REGULATES CONDITIONED STRESS-INDUCED METABOLIC-ACTIVATION OF THE MESOPREFRONTAL CORTICAL DOPAMINE BUT NOT SEROTONIN SYSTEMS - A BEHAVIORAL, NEUROENDOCRINE,AND NEUROCHEMICAL STUDY IN THE RAT()), The Journal of neuroscience, 14(8), 1994, pp. 4937-4950
Citation: B. Moghaddam et Bs. Bunney, DEPOLARIZATION INACTIVATION OF DOPAMINE NEURONS - TERMINAL RELEASE CHARACTERISTICS, Synapse, 14(3), 1993, pp. 195-200
Authors:
MAREK KL
SPENCER DD
NAFTOLIN F
ROBBINS RJ
FARHI AE
SERRANO CC
VOLLMER TL
GERBER A
LEVY L
LERANTH C
ROTH RH
BUNNEY BS
SASS KJ
PRICE LH
REDMOND DE
Citation: Kl. Marek et al., EFFECTS OF HUMAN FETAL MESENCEPHALIC TISSUE IMPLANTATION OF THE CAUDATE-NUCLEUS IN PARKINSONIAN-PATIENTS, Neurology, 43(4), 1993, pp. 154-154